Company intelligence / Profile preview

CelRevive

Birmingham, Alabama, United States

Ownership: Private
Development stage: Other

Overview

CelRevive is a biotechnology company focused on developing next-generation regenerative medicines for cardiovascular diseases. The company leverages induced pluripotent stem cell (iPSC) technology to create high-purity, functional cardiomyocytes intended to repair damaged heart tissue. By focusing on scalable manufacturing and advanced cell delivery methods, CelRevive aims to address the underlying causes of heart failure and ischemic heart disease. Their approach seeks to provide a definitive therapeutic solution for patients with limited options following myocardial injury.

Therapeutic areas: Cardiovascular
Modalities: Cell therapyInduced pluripotent stem cell derived therapy
Industry: Biotech

Beyond the preview

Go deeper on CelRevive.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CelRevive.

Explore the full profile